GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantech Holding Inc (OTCPK:BSSP) » Definitions » Growth Rank

Cantech Holding (Cantech Holding) Growth Rank : 0 (As of May. 19, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Cantech Holding Growth Rank?

Cantech Holding has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Cantech Holding Growth Rank Related Terms

Thank you for viewing the detailed overview of Cantech Holding's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantech Holding (Cantech Holding) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantech Holding Inc (OTCPK:BSSP) » Definitions » Growth Rank
Comparable Companies
HSTC NTRR TLOG NSPX ERGO OPLI GLAG FPMI ADYNF ENTB CAPS BTHE GOVX LCAR ARNI IMUC CTBO GNBT ICOTF TIKRF
Traded in Other Exchanges
N/A
Address
120 W Pomona Avenue, Monrovia, CA, USA, 91016
Website
http://www.cantechholding.com
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company's product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.
Executives
Pamela Elliott officer: Secretary and Treasurer 1960 GRAEAGLE LANE, LINCOLN CA 95648